[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367676-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367676-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","delta-like-ligand-3-expression-and-functional-imaging-in-gastroenteropancreatic-neuroendocrine-neoplasms","Delta-like ligand 3 expression and functional imaging in gastroenteropancreatic neuroendocrine neoplasms","","Delta-like ligand 3 (DLL3) expression and functional imaging are investigated in gastroenteropancreatic neuroendocrine neoplasms. The work is presented as a medRxiv preprint and includes a study team spanning clinical medicine, epidemiology/biostatistics, pathology and laboratory medicine, radiology, and molecular oncology. The preprint specifies research not certified by peer review and reports manuscript-level details such as figures, tables, supplementary materials, disclosures, and co-senior authorship.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/delta-like-ligand-3-expression-and-functional-imaging-in-gastroenteropancreatic-neuroendocrine-neoplasms/367676/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/delta-like-ligand-3-expression-and-functional-imaging-in-gastroenteropancreatic-neuroendocrine-neoplasms/367676.png","ImageObject",300,407,{"name":42,"@type":43},"Adam","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the document about?","Question",{"text":63,"@type":64},"The preprint focuses on DLL3 expression and functional imaging in gastroenteropancreatic neuroendocrine neoplasms.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Is the research peer-reviewed?",{"text":68,"@type":64},"No. It states that the preprint was not certified by peer review and should not guide clinical practice.",{"name":70,"@type":61,"acceptedAnswer":71},"Who are the co-senior authors and corresponding author?",{"text":72,"@type":64},"The preprint lists corresponding author Rohit Thummalapalli, and notes Drs. Dunphy and Raj as co-senior authors.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367676,1790748904,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":102,"preview_urls":146},1374404737137,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","medRxiv preprint doi: [https://doi.org/10.1101/2025.06.24.25330227](https://doi.org/10.1101/2025.06.24.25330227); this version posted June 25, 2025. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.  \nIt is made available under a CC-BY-ND 4.0 International license .  \nDelta-like ligand 3 expression and functional imaging in gastroenteropancreatic neuroendocrine neoplasms  \nRohit Thummalapalli 1 , Salomon Tendler1 , Joanne F. Chou2 , Zeynep C. Tarcan3 , Courtney Porfido 1 , Jonathan Willner3 , Irina Linkov4 , Umesh Bhanot3 , Alissa J. Cooper1 , Jierui Xu5 , James J. Harding 1 , Natasha Rekhtman3 , Laura H. Tang3 , Charles M. Rudin 1 , Yelena Y. Janjigian 1 , Heiko Schöder6 , John T. Porier7 , Jinru Shia3 , Olca Basturk3 , Diane Reidy-Lagunes 1 , Marinela Capanu2 , Jason S. Lewis6 , Lisa Bodei6 , Mark P. Dunphy*6 , Nitya Raj* 1  \n1. Department of Medicine, Memorial Sloan Kettering Cancer Center, New York,  \nNY.  \n2. Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.  \n3. Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.  \n4. Pathology Core Facility, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.  \n5. Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.  \n6. Department of Radiology, Memorial Sloan Kettering Cancer Center, New York,  \nNY.  \n7. Perlmutter Cancer Center, New York University Langone Health, New York, NY.  \nNOTE: This preprint reports new research that has not been certifid by peer review and should not be used to guide clinical practice.  \nmedRxiv preprint doi: [https://doi.org/10.1101/2025.06.24.25330227](https://doi.org/10.1101/2025.06.24.25330227); this version posted June 25, 2025. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.  \nIt is made available under a CC-BY-ND 4.0 International license .  \n* = Drs. Dunphy and Raj are co-senior authors.  \nCorresponding author:  \nRohit Thummalapalli  \n300 E 66th Street New York, NY 10065  \nWord count: 3978  \nFigures: 4  \nTables: 2  \nSupplementary Figures: 6  \nSupplementary Tables: 6  \nDisclosures/conflicts of interest:  \nRohit Thummalapalli: Honoraria and travel support from MJH Life Sciences.  \nJoanne F. Chou: Stock or other ownership interests: PAIGE.AI (Institutional) .  \nSalomon Tendler: Inventor on a patent “Anti-DLL3 antibodies IP” (Patent No. 63/240,237) .  \nAlissa J. Cooper: Honoraria from MJH Life Sciences, Ideology Health, Intellisphere LLC, MedStar Health and CancerGRACE. Consulting fees from Gilead Sciences, Inc, Daiichi/Astra Zeneca, Novartis, and Regeneron. Research funding to institution from Merck, Monte Rosa, AbbVie, Roche, Daiichi Sankyo, and Amgen.  \nmedRxiv preprint doi: [https://doi.org/10.1101/2025.06.24.25330227](https://doi.org/10.1101/2025.06.24.25330227); this version posted June 25, 2025. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.  \nIt is made available under a CC-BY-ND 4.0 International license .  \nJames J. Harding: Research support from AbbVie, AstraZeneca, BMS, Boehringer Ingelheim, Jazz, and Zymeworks. Consulting fees from Amgen, AstraZeneca, BMS, Boehringer Ingelheim, Cogent, Elevar, Exelexis, Merck, RayzeBio, Servier, and Jazz. Charles M. Rudin: Consultant for Amgen, AstraZeneca, Boehringer Ingelheim, . Chugai Pharmaceuticals, D2G Oncology, Daiichi Sankyo, F. Hoffmann-LaRoche, Jazz Therapeutics, Legend, Novartis, Scorpion Therapeutics. Scientific advisory board for Auron, Bridge Medicines, DISCO, Earli, Harpoon Therapeutics. Inventor on a patent“A","cbCaigir1dU9XIzl","https://ap.wps.com/l/cbCaigir1dU9XIzl","pdf",1530636,53,"English","# Delta-like ligand 3 expression and functional imaging in gastroenteropancreatic neuroendocrine neoplasms","[{\"question\":\"What is the document about?\",\"answer\":\"The preprint focuses on DLL3 expression and functional imaging in gastroenteropancreatic neuroendocrine neoplasms.\"},{\"question\":\"Is the research peer-reviewed?\",\"answer\":\"No. It states that the preprint was not certified by peer review and should not guide clinical practice.\"},{\"question\":\"Who are the co-senior authors and corresponding author?\",\"answer\":\"The preprint lists corresponding author Rohit Thummalapalli, and notes Drs. Dunphy and Raj as co-senior authors.\"}]","Delta-like ligand 3 expression and functional imaging in gastroenteropancreatic neuroendocrine neoplasms | PDF",1790171922,134,[147,151,155,159,163,167],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2c971609fc8a33ae3fcd3119e0254aa5.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f2e3ca4313b1624a65f72ac556e5138e.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d8431c3fbb7366f5b92d46165bc898af.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/721a03969dbe8bb75e18329910219ec6.webp",980,1268,{"page_no":97,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4e65457bf4b77c567c4e678b1eae8ab7.webp",979,1267,{"page_no":102,"url":168,"width":169,"height":170},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7aadd96c262047e772f60b5a05163684.webp",978,1265]